Picture of NDT Pharmaceuticals logo

NDTP NDT Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for NDT Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2007
December 31st
2008
December 31st
R2009
December 31st
2010
December 31st
2011
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-KARSARSARSARS
Standards:
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.04-0.052-1.04-0.246-0.031
Non-Cash Items0.9850.01710.189
Other Non-Cash Items
Changes in Working Capital0.0130.004-0.2910.043-1.02
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-0.039-0.031-0.326-0.015-1.05
Financing Cash Flow Items10
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.030.10.3220.0191.23
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.070.069-0.0050.0050.181